These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 22516927
1. D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis. Smee DF, Hurst BL, Day CW. Antivir Chem Chemother; 2012 Aug 21; 22(6):263-72. PubMed ID: 22516927 [Abstract] [Full Text] [Related]
3. Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice. Liu Z, Guo Z, Wang G, Zhang D, He H, Li G, Liu Y, Higgins D, Walsh A, Shanahan-Prendergast L, Lu J. Eur J Pharm Sci; 2009 Oct 08; 38(3):215-23. PubMed ID: 19616097 [Abstract] [Full Text] [Related]
6. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase. Ding Y, Dou J, Teng Z, Yu J, Wang T, Lu N, Wang H, Zhou C. Arch Virol; 2014 Dec 08; 159(12):3269-78. PubMed ID: 25078390 [Abstract] [Full Text] [Related]
7. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents. Yu M, Liu A, Du G, Naesens L, Vanderlinden E, De Clercq E, Liu X. Chem Biol Drug Des; 2011 Oct 08; 78(4):596-602. PubMed ID: 21752202 [Abstract] [Full Text] [Related]
8. Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis. Murray JL, McDonald NJ, Sheng J, Shaw MW, Hodge TW, Rubin DH, O'Brien WA, Smee DF. Antivir Chem Chemother; 2012 May 14; 22(5):205-15. PubMed ID: 22374988 [Abstract] [Full Text] [Related]
9. [In vitro and in vivo anti-influenza virus activity of ribavirin injection]. Gao RM, Li XQ, He WY, Jiang JD, Li YH. Yao Xue Xue Bao; 2010 Mar 14; 45(3):403-7. PubMed ID: 21351521 [Abstract] [Full Text] [Related]
11. Antiviral activity of recombinant mouse β-defensin 3 against influenza A virus in vitro and in vivo. Jiang Y, Yang D, Li W, Wang B, Jiang Z, Li M. Antivir Chem Chemother; 2012 Aug 21; 22(6):255-62. PubMed ID: 22345365 [Abstract] [Full Text] [Related]
13. (-)-Carbodine: enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu). Rao JR, Jha AK, Rawal RK, Sharon A, Day CW, Barnard DL, Smee DF, Chu CK. Bioorg Med Chem Lett; 2010 Apr 15; 20(8):2601-4. PubMed ID: 20231094 [Abstract] [Full Text] [Related]
14. Discovery of highly potent agents against influenza A virus. Zhao X, Li C, Zeng S, Hu W. Eur J Med Chem; 2011 Jan 15; 46(1):52-7. PubMed ID: 21094565 [Abstract] [Full Text] [Related]
16. Anti-influenza A virus activity of uridine derivatives of 2-deoxy sugars. Krol E, Wandzik I, Gromadzka B, Nidzworski D, Rychlowska M, Matlacz M, Tyborowska J, Szewczyk B. Antiviral Res; 2013 Oct 15; 100(1):90-7. PubMed ID: 23911991 [Abstract] [Full Text] [Related]
19. In vitro and in vivo influenza virus-inhibitory effects of viramidine. Sidwell RW, Bailey KW, Wong MH, Barnard DL, Smee DF. Antiviral Res; 2005 Oct 15; 68(1):10-7. PubMed ID: 16087250 [Abstract] [Full Text] [Related]